Catalyst Financial Partners’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $501K | Buy |
4,517
+508
| +13% | +$56.3K | 0.05% | 165 |
|
|
2025
Q1 | $449K | Buy |
4,009
+238
| +6% | +$26.7K | 0.08% | 164 |
|
|
2024
Q4 | $348K | Sell |
3,771
-1,564
| -29% | -$144K | 0.07% | 186 |
|
|
2024
Q3 | $447K | Buy |
5,335
+421
| +9% | +$35.3K | 0.09% | 149 |
|
|
2024
Q2 | $337K | Buy |
4,914
+562
| +13% | +$38.6K | 0.07% | 170 |
|
|
2024
Q1 | $291K | Sell |
4,352
-798
| -15% | -$53.4K | 0.07% | 173 |
|
|
2023
Q4 | $417K | Buy |
5,150
+261
| +5% | +$21.1K | 0.12% | 116 |
|
|
2023
Q3 | $366K | Buy |
4,889
+298
| +6% | +$22.3K | 0.12% | 129 |
|
|
2023
Q2 | $354K | Buy |
4,591
+557
| +14% | +$42.9K | 0.13% | 118 |
|
|
2023
Q1 | $335K | Buy |
4,034
+355
| +10% | +$29.5K | 0.14% | 111 |
|
|
2022
Q4 | $316K | Buy |
+3,679
| New | +$316K | 0.16% | 101 |
|